EyePoint Pharmaceuticals (EYPT) Tops Q1 EPS by 11c

EyePoint Pharmaceuticals (NASDAQ: EYPT) reported Q1 EPS of ($0.56), $0.11 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $7.39 million versus the consensus estimate of $7.91 million.

For earnings history and earnings-related data on EyePoint Pharmaceuticals (EYPT) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Twin Disc (TWIN) Tops Q4 EPS by 16c
• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%